Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (CSE: $ABCS.C) (NYSE: $CVS) (CSE: $CURA.C) (TSXV: $VIVO.V)
Delta, Kelowna, BC –May 10, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/05101ABCS-CVS-CURA-VIVO.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast I look at a few of the day’s earlier announcements.
But first, the Louisiana House of Representatives amended a bill seeking to legalize growing hemp in the state to also include legalizing the sale of CBD oil.
CBD products have been in a legal gray area, in that stores permitted by the Louisiana Office of Alcohol and Tobacco Control have not been allowed to sell it but other stores have.
House Bill 491 as amended would clarify the law and allow CBD to be sold legally in Louisiana as long as it is not smoked or included in food or beverages, said Rep. Clay Schexnayder, the Gonzales Republican who authored the bill.
The primary purpose of the bill is to allow Louisiana farmers to grow hemp, which can be used in a variety of products, under rules created by the federal government and the Louisiana Department of Agriculture and Forestry.
The department would license growers, track acreage, inspect crops, and potentially seize and destroy plants with too much THC.
While the federal USDA hasn’t yet issued rules governing hemp farming, Agriculture and Forestry Commissioner Mike Strain says he wants to make sure the state is ready to go when the federal rules are.
Abacus Health Products, Inc. (CSE: ABCS) today announced further growth in the distribution and availability of their line of CBDMEDIC™ products.
New purchase orders from four U.S. retail chains, including Kinney Drugs, SuperValu (a division of UNFI) and Tops Markets, increases the availability of CBDMEDIC™ products to over 1,400 pharmacy and supermarket retail locations throughout the United States. Additionally, CVS (NYSE: CVS) will be offering the CBDMEDIC™ Foot Pain product to 440 stores.
"These purchase orders, which range from six to twelve unique SKUs across our pain relief and therapeutic skincare lines, demonstrate the continued strong interest by retail chains to bring CBDMEDIC™ products onto their shelves," said Perry Antelman, CEO of Abacus. "We are also delighted that CVS will be expanding the offering of CBDMEDIC™ products to include our Foot Pain Solid Stick, further reinforcing our position as a leader in the segment."
The American Academy of Pain Medicine has estimated that chronic pain affects approximately 100 million Americans. Further, a 2018 research report by Allied Market Research estimated the global topical pain relief market to be approximately US$7.4 billion in 2017.
According to the American Academy of Dermatology Association, a form of skin disease affects over 84 million Americans, with the total cost of those diseases including US$15 billion in prescription drugs and US$10 billion in over-the-counter products.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced the launch of Bido, hemp-based CBD products for pets. CBD is a non-intoxicating, non-psychoactive compound from the cannabis sativa plant. CBD has been shown in initial third-party studies to support a pet's overall wellness including the potential to help manage pain and anxiety. Bido pet drops come in three varieties, bacon, salmon and unflavored "pure," and Bido soft-baked bites are available in apple chicken, peanut butter bacon, and honey sweet potato. All Bido products can be purchased online at www.curaleafhemp.com.
Bido's tasty products were developed using 100 percent natural and U.S. grown hemp that was tested and extracted to the highest industry standards. Curaleaf's team of scientists transformed the hemp-based CBD oil into a product with a precise dosage and flavor for pets. Product photos are available for download here.
All Bido products undergo strict laboratory testing before formulation as well as batch testing on the final products before distribution. Lab results are available upon request.
"Our human customers are already reaping the benefits of CBD with Curaleaf Hemp. The same care and research went into the development of Bido. We are excited to be extending our high quality, trusted products to pet owners," said Joe Lusardi, President and Chief Executive Officer of Curaleaf. "The launch of Bido is just one more way we are the most accessible cannabis company in the U.S."
VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQB: VVCIF) announced that its wholly-owned subsidiary, Canna Farms Limited, has completed registration with Alberta Gaming, Liquor & Cannabis to supply the Province of Alberta with its well-recognized premium cannabis products. Canna Farms is preparing its first shipments for immediate delivery to AGLC.
"We are very excited to bring our premium products to the Alberta consumer market, one of the strongest in Canada, and fill some of the current industry supply gaps while continuing to expand our distribution channels," said Daniel Laflamme, President of Canna Farms. "Following Health Canada's approval of our facility expansion, allowing us to double our current production capacity, we are eager to expand our customer base in Alberta, where the Canna Farms brand is well-known, and look forward to shipping to all Canadian provinces and territories in 2019 in connection with our production ramp-up."
"To facilitate efficient shipping, we have invested in automated packaging and labelling equipment to address some of the downstream challenges faced by producers in getting their products to market," added Brian McDonald, Vice-President of Canna Farms. "We are also actively working on developing different concentrates and edible products, and using automation to expedite the production process. Having Alberta as a long-term partner, and continuing to invest in premium quality indoor production, will help us to continue to differentiate Canna Farms as a true premium cannabis company and a market leader in quality and reliable supply."
According to research firms BDS Analytics and Arcview Market Research, the Alberta consumer cannabis market is expected to grow to become the second largest in Canada by 2024, with estimated annual sales of $940 million.
"Alberta is a very important partner to us as our premium products are already well established in the medical market, through our approximately 18,000 registered medical clients and VIVO's wholly owned subsidiary, Harvest Medicine, which operates across the country and has approximately 27,000 patients," stated Mr. Laflamme. "Recent Health Canada data indicates that fewer recreational users are buying cannabis oils, as compared to flower products. As our premium flower products are of superior quality to the mid-grade products that make up much of the recreational market, we believe Canna Farms is strongly positioned to offer an enhanced user experience to our customers."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment